Começar
Artofchart

Accumulate, Hold for Long term

Viés de alta
STRIDES PHARMA SCI (NSE:STAR)  
Artofchart  
NSE:STAR   STRIDES PHARMA SCI
Trend Analysis Fundamental Analysis stridespharma long-term
1
3
trendanalysis fundamental stridespharma long-term
Excellent Opportunity to buy the stock. Strides revenues in Q4FY21 grew by 47% YoY to Rs.908 cr during the quarter with sales growth in the regulated markets and emerging markets.

I have entered around the 770 mark as Investment and plan to hold for long term

Chart study, not a call
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.